Coya Therapeutics, Inc. (COYA): Total Assets
$49.95M
As of 2025-12-31
$47.31M
As of 2026-06-30
+81.2%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $49.95M | +12.6% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $44.35M | +7.5% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $41.26M | +391.5% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $8.40M | +75.2% | 2024-03-19, Balance as of period end |
| 2021-12-31 | $4.79M | n/a | 2023-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $49.95M | +12.6% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $160.46M | -27.2% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $56.75M | -43.0% |
| Adagene Inc. (ADAG) | 2025-12-31 | $78.26M | -12.3% |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | $5.71B | +5.0% |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | $633.16M | -20.7% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $150.93M | +63.8% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $150.83M | +114.5% |
| BioAge Labs, Inc. (BIOA) | 2025-12-31 | $294.89M | -17.7% |
Compare COYA, ACRS, BOLT, ADAG side by side · Screen every company in Pharmaceutical Preparations ↗